STOCK TITAN

Monthly information on share capital and company voting rights

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Cellectis has released its monthly update on share capital and voting rights as of May 31, 2024. The company, listed on Euronext Growth with ISIN code FR0010425595, reports a total of 100,093,635 shares in its capital. The number of voting rights stands at 88,029,374. For more details, media and investor relations contacts are provided.

Positive
  • The company has a substantial number of shares, indicating a large capital base.
  • Maintaining regular updates on share capital and voting rights promotes transparency.
Negative
  • The voting rights are significantly lower than the total number of shares, potentially indicating diluted voting power for shareholders.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, June 05, 2024 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

DateTotal number of shares
in the capital
Total number of voting rights
05/31/2024100,093,63588,029,374

For further information on Cellectis, please contact:     

Media contact:       

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contacts:       

Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com

Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577  

Attachment


FAQ

What is the total number of shares for Cellectis as of May 31, 2024?

The total number of shares for Cellectis as of May 31, 2024, is 100,093,635.

How many voting rights does Cellectis have as of May 31, 2024?

As of May 31, 2024, Cellectis has 88,029,374 voting rights.

On which market is Cellectis listed?

Cellectis is listed on Euronext Growth.

What is the ISIN code for Cellectis?

The ISIN code for Cellectis is FR0010425595.

Who can I contact for more information about Cellectis?

For more information, you can contact Pascalyne Wilson, Director of Communications, or Patricia Sosa Navarro, Chief of Staff to the CEO. Investor relations contacts include Arthur Stril and Ashley R. Robinson.

Cellectis S.A. American Depositary Shares

NASDAQ:CLLS

CLLS Rankings

CLLS Latest News

CLLS Stock Data

181.17M
72.09M
3.87%
14.59%
0.35%
Biotechnology
Healthcare
Link
United States of America
Paris